Predictors of persistent disease in biologic treated type 2 diffuse/eosinophilic chronic rhinosinusitis undergoing surgery.
Lu Hui PngLarry KalishRaewyn G CampbellKachorn SeresirikachornTobias AlbrechtNelufer RajiChristine ChoyJanet RimmerPeter EarlsRaymond SacksRichard John HarveyPublished in: International forum of allergy & rhinology (2023)
cells/L predicts for poor response to current biologic therapy.